Skip to content

Reiki Therapy - an Intervention in Hematology/Oncology Cancer Patients Hospitalized

Reiki Therapy - an Intervention in Hematology/Oncology Cancer Patients Hospitalized in an Inpatient Setting - a Pilot Study.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03946865
Enrollment
0
Registered
2019-05-13
Start date
2019-07-10
Completion date
2021-04-01
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

Researchers are trying to determine if offering and providing reiki therapy in hospitalized hematology/oncology cancer subjects has any effects on symptoms and feeling during the subjects hospital stay.

Detailed description

Primary Aim: The primary aim of this study is to evaluate the feasibility of offering and providing Reiki Therapy in hospitalized hematology/oncology cancer patients. The intervention should not - interfere with the medical management of the participants. The investigators hypothesize that Reiki Sessions will be successfully integrated into conventional care of hospitalized cancer patients. Secondary Aim: The secondary aim is to evaluate the patient reported outcomes of their symptoms (pain, fatigue, anxiety) and feelings (happy, energetic, relaxed, and calm) before and after Reiki Therapy. The investigators' hypothesis is that there will be improvement of patients' symptoms/feelings score after the Reiki Therapy.

Interventions

Reiki is a healing practice that originated in Japan. Reiki practitioners place their hands lightly on or just above the person receiving treatment, with the goal of facilitating the person's own healing response.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Hospitalized hematology-oncology patients age 18 - 80 * Able to speak English and complete surveys * Able to read, understand and sign inform consent.

Exclusion criteria

* Patient unwilling for reiki therapy. * Unable to give written consent. * Already having received or receiving other reiki treatment. * Pregnant women. (As verbalized by participant)

Design outcomes

Primary

MeasureTime frameDescription
Change in pain pain symptomsBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is not at all and 10 is unbearable
Change in fatigue symptomsBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is not at all and 10 is unbearable
Change in anxiety symptomsBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is not at all and 10 is unbearable
Change in feeling happyBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is best possible and 10 is worst possible
Change in feeling energizedBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is best possible and 10 is worst possible
Change in feeling relaxedBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is best possible and 10 is worst possible
Change in feeling calmBaseline, approximately 2 hoursMeasured using a numeric rating scale, where 0 is best possible and 10 is worst possible

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026